These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33021054)

  • 1. Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
    Zoetemelk M; Ramzy GM; Rausch M; Koessler T; van Beijnum JR; Weiss A; Mieville V; Piersma SR; de Haas RR; Delucinge-Vivier C; Andres A; Toso C; Henneman AA; Ragusa S; Petrova TV; Docquier M; McKee TA; Jimenez CR; Daali Y; Griffioen AW; Rubbia-Brandt L; Dietrich PY; Nowak-Sliwinska P
    Mol Oncol; 2020 Nov; 14(11):2894-2919. PubMed ID: 33021054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
    Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
    Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-severe aortic regurgitation increases short-term mortality in acute heart failure with preserved ejection fraction.
    Abdurashidova T; Monney P; Tzimas G; Soborun N; Regamey J; Daux A; Barras N; Kirsch M; Müller M; Hullin R
    ESC Heart Fail; 2020 Dec; 7(6):3901-3909. PubMed ID: 33026164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avapritinib for metastatic or unresectable gastrointestinal stromal tumors.
    Alzofon N; Jimeno A
    Drugs Today (Barc); 2020 Sep; 56(9):561-571. PubMed ID: 33025950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor.
    Zhang JQ; Bosbach B; Loo JK; Vitiello GA; Zeng S; Seifert AM; Medina BD; Param NJ; Maltbaek JH; Rossi F; Antonescu CR; Besmer P; DeMatteo RP
    Oncogene; 2020 Dec; 39(49):7153-7165. PubMed ID: 33024275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.
    Rausch M; Weiss A; Zoetemelk M; Piersma SR; Jimenez CR; van Beijnum JR; Nowak-Sliwinska P
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.
    Benboubker V; Ramzy GM; Jacobs S; Nowak-Sliwinska P
    J Exp Clin Cancer Res; 2024 Sep; 43(1):259. PubMed ID: 39261955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy.
    Wang Z; Li W; Jiang Y; Tran TB; Chung J; Kim M; Scott AJ; Lu J
    Biomaterials; 2024 Apr; 306():122477. PubMed ID: 38309054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine.
    Rago V; Perri A; Di Agostino S
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titin as a potential novel therapeutic target in colorectal cancer.
    Wei H; Ren K; Zhang Q; Jin Y; Cao B; Tian Z; Mao T; Ren L
    J Cell Mol Med; 2023 Oct; 27(19):2937-2944. PubMed ID: 37499109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma.
    Ramzy GM; Norkin M; Koessler T; Voirol L; Tihy M; Hany D; McKee T; Ris F; Buchs N; Docquier M; Toso C; Rubbia-Brandt L; Bakalli G; Guerrier S; Huelsken J; Nowak-Sliwinska P
    J Exp Clin Cancer Res; 2023 Apr; 42(1):79. PubMed ID: 37013646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer.
    Hany D; Zoetemelk M; Bhattacharya K; Nowak-Sliwinska P; Picard D
    Cell Mol Life Sci; 2023 Mar; 80(3):80. PubMed ID: 36869202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells.
    Ramzy GM; Boschung L; Koessler T; Delucinge-Vivier C; Docquier M; McKee TA; Rubbia-Brandt L; Nowak-Sliwinska P
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying mutant-specific multi-drug combinations using comparative network reconstruction.
    Bosdriesz E; Fernandes Neto JM; Sieber A; Bernards R; Blüthgen N; Wessels LFA
    iScience; 2022 Aug; 25(8):104760. PubMed ID: 35992065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.
    Rausch M; Rutz A; Allard PM; Delucinge-Vivier C; Docquier M; Dormond O; Dyson PJ; Wolfender JL; Nowak-Sliwinska P
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells.
    Rausch M; Rutz A; Allard PM; Delucinge-Vivier C; Docquier M; Dormond O; Wolfender JL; Nowak-Sliwinska P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets.
    Rausch M; Blanc L; De Souza Silva O; Dormond O; Griffioen AW; Nowak-Sliwinska P
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forcing dividing cancer cells to die; low-dose drug combinations to prevent spindle pole clustering.
    Ducrey E; Castrogiovanni C; Meraldi P; Nowak-Sliwinska P
    Apoptosis; 2021 Jun; 26(5-6):248-252. PubMed ID: 33870441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and Challenges in Tunneling Nanotubes Research: How Far from Clinical Application?
    Han X; Wang X
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669068
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.